EXOZYMES INC.
EXOZ · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4/A ·
Latest disclosures
-
Korman Tyler Paz: Form 4/A
Insider disclosure · Filed · Report period 19 Aug 2026
-
Form 4/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- EXOZ · 461874109 - COM
Company details and SEC sources
CIK 0002010788 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- EXOZ on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 750 Royal Oaks Dr, Monrovia, CA, 91016
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
- Invizyne Technologies Inc (to 21 Jan 2025)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields